Table 5.
< 150mg/m2 (n = 39) | 150 ~ 300mg/m2 (n = 23) | 300 ~ 450mg/m2 (n = 29) | > 450mg/m2 (n = 38) | F | p | |
---|---|---|---|---|---|---|
GPBB | ||||||
Before chemotherapy | 22.34 ± 7.29 | 22.74 ± 5.60 | 23.06 ± 8.31 | 22.08 ± 4.39 | 0.139 | 0.936 |
After chemotherapy | 23.68 ± 4.12 | 29.86 ± 4.03*@ | 33.68 ± 4.79*&@ | 42.06 ± 5.44*&#@ | 101.8 | < 0.001 |
Mb | ||||||
Before chemotherapy | 29.56 ± 10.07 | 31.46 ± 12.74 | 33.78 ± 15.65 | 32.35 ± 12.72 | 0.660 | 0.578 |
After chemotherapy | 31.93 ± 12.64 | 44.66 ± 15.30*@ | 59.82 ± 9.80*&@ | 52.05 ± 13.76*@ | 29.22 | <0.001 |
BNP | ||||||
Before chemotherapy | 31.20 ± 14.41 | 29.61 ± 16.91 | 28.77 ± 13.22 | 31.98 ± 15.65 | 0.306 | 0.821 |
After chemotherapy | 51.74 ± 15.10@ | 70.02 ± 25.06*@ | 88.45 ± 23.71*&@ | 75.53 ± 30.92*@ | 13.6 | <0.001 |
LVEF | ||||||
Before chemotherapy | 55.27 ± 5.66 | 57.03 ± 5.71 | 55.91 ± 5.33 | 57.36 ± 4.97 | 1.147 | 0.333 |
After chemotherapy | 59.20 ± 3.97@ | 54.50 ± 4.09* | 51.07 ± 3.61*&@ | 47.81 ± 5.39*&#@ | 46.33 | < 0.001 |
E/A | ||||||
Before chemotherapy | 1.28 ± 0.33 | 1.30 ± 0.33 | 1.22 ± 0.36 | 1.27 ± 0.29 | 0.347 | 0.792 |
After chemotherapy | 1.13 ± 0.05@ | 1.13 ± 0.04@ | 1.12 ± 0.06 | 1.10 ± 0.08@ | 1.948 | 0.125 |
EDT/ms | ||||||
Before chemotherapy | 173.64 ± 36.53 | 172.26 ± 42.26 | 171.94 ± 29.29 | 173.81 ± 36.10 | 0.022 | 0.996 |
After chemotherapy | 189.83 ± 23.03@ | 197.72 ± 28.55@ | 189.28 ± 22.07@ | 191.74 ± 29.09@ | 0.572 | 0.634 |
IVRT/ms | ||||||
Before chemotherapy | 81.76 ± 12.35 | 82.49 ± 6.90 | 81.91 ± 10.36 | 82.07 ± 11.66 | 0.023 | 0.995 |
After chemotherapy | 68.24 ± 20.40@ | 68.71 ± 14.01@ | 68.57 ± 17.97@ | 68.23 ± 14.74@ | 0.006 | 0.999 |
Note: GPBB, glycogen phosphorylase isoenzyme BB; Mb, myoglobin; BNP, brain natriuretic peptide; LVEF, left ventricular ejection fraction; E/A, mitral ratio of peak early to late diastolic filling velocity; IVRT, isovolumic relaxation time; EDT, E-wave deceleration time. *, p < 0.05 vs group of < 150mg/m2; &, p < 0.05 vs group of 150 ~ 300mg/m2; #, p < 0.05 vs group of 300 ~ 450mg/m2; @, p < 0.05 vs levels or values before chemotherapy.